GLI ANTAGONISTI DELLA IL-6 RIDUCONO LA MORTALITA’ DA COVID-19 NEGLI OSPEDALIZZATI: UNA META-ANALISI DAL GRUPPO WHO

COVID19 - EVIDENCE, INTERNATIONAL SNAPSHOTS, MEDICINA INTERNALascia un commento

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19. A Meta-analysis The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group Key PointsQuestion  Is administration of IL-6 antagonists associated with 28-day all-cause mortality in patients hospitalized for COVID-19? Findings  This prospective meta-analysis of 27 randomized trials included 10 930 patients, of whom 2565…

POVERA EBM: I DUBBI SULL’ULTIMO TRIAL ANTI COVID-19. RIDUZIONE DELLA MORTALITA’ DEL 77% ? DA “SCIENCE”

COVID19 - EVIDENCE, METODOLOGIA, Senza categoriaLascia un commento

‘Too good to be true’: Doubts swirl around trial that saw 77% reduction in COVID-19 mortality Robert F. Service Science’s COVID-19 reporting is supported by the Heising-Simons Foundation. It would be the best news by far in COVID-19 treatment: According to a preprint published on 22 June, an experimental prostate cancer drug named proxalutamide reduced deaths…

LE NUOVE TERAPIE PER LA OBESITA’. UN PUNTO DI VISTA IN 2 PAGINE SU JAMA

EPATOLOGIA, MEDICI DI FAMIGLIA, MEDICINA INTERNA, NUTRIZIONE, Senza categoriaLascia un commento

Progress in Pharmacotherapy for Obesity Susan Z. Yanovski et al. The obesity epidemic in the US continues unabated. The elevated risk for severe disease and death from COVID-19 associated with obesity and its comorbidities underscores the urgency to develop and implement effective prevention and treatment strategies. Multicomponent behavior-based weight management interventions are recommended for adults…

DIAGNOSI E TERAPIA DELLA MALATTIA EPATICA DA ALCOL: UNA REVISIONE DA JAMA

CIRROSI EPATICA, EPATOLOGIA, MEDICI DI FAMIGLIA, MEDICINA INTERNA, NUTRIZIONE, Senza categoriaLascia un commento

Diagnosis and Treatment of Alcohol-Associated Liver Disease A Review Ashwani K. Singal, MD; Philippe Mathurin, MD IMPORTANCE Alcohol-associated liver disease results in cirrhosis in approximately 10% to 20% of patients. In 2017, more than 2 million people had alcohol-associated cirrhosis in the US. Alcohol-associated liver disease is the primary cause of liver-related mortality and the…

INTRODUZIONE ALLA ANALISI STATISTICA DEI DATI CLINICI IN 15′ MINUTI! PROVARE PER CREDERE

METODOLOGIA, Senza categoriaLascia un commento

Statistical Analysis of Biomedical Data — an Overview From p-values and regression to clustering and classification Sukanta Saha The last decade has seen an enormous boom in the production of patient data. From wearables like smartwatches logging our heart rates to RNA sequencing for differential expression, our ability to monitor and observe individual patients’ health…

I TEST DI DIAGNOSI PER LA FIBROSI NELLA NAFLD: UNA META-ANALISI PER DATI INDIVIDUALI PER RIDURRE LE BIOPSIE

EPATOLOGIA, GASTROENTEROLOGIA, MEDICI DI FAMIGLIA, MEDICINA INTERNALascia un commento

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis Ferenc Emil Mózes et al. ABSTRACT Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic fatty liver disease. The aims of this study were to evaluate the individual diagnostic performance of liver stiffness measurement…